CryoLife Valuation
| CYL Stock | EUR 26.65 0.10 0.37% |
At this time, the firm appears to be undervalued. CryoLife shows a prevailing Real Value of €30.9 per share. The current price of the firm is €26.65. Our model approximates the value of CryoLife from analyzing the firm fundamentals such as Current Valuation of 796.78 M, profit margin of (0.06) %, and Return On Equity of -0.0656 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that CryoLife's price fluctuation is very steady at this time. Calculation of the real value of CryoLife is based on 3 months time horizon. Increasing CryoLife's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CryoLife stock is determined by what a typical buyer is willing to pay for full or partial control of CryoLife. Since CryoLife is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CryoLife Stock. However, CryoLife's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.65 | Real 30.9 | Hype 26.65 | Naive 25.62 |
The real value of CryoLife Stock, also known as its intrinsic value, is the underlying worth of CryoLife Company, which is reflected in its stock price. It is based on CryoLife's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CryoLife's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CryoLife helps investors to forecast how CryoLife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CryoLife more accurately as focusing exclusively on CryoLife's fundamentals will not take into account other important factors: CryoLife Total Value Analysis
CryoLife is currently estimated to have takeover price of 796.78 M with market capitalization of 506.16 M, debt of 306.5 M, and cash on hands of 40.26 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CryoLife fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
796.78 M | 506.16 M | 306.5 M | 40.26 M |
CryoLife Investor Information
About 87.0% of the company shares are held by institutions such as insurance companies. The book value of CryoLife was currently reported as 7.05. The company has Price/Earnings (P/E) ratio of 303.28. CryoLife recorded a loss per share of 0.44. The entity last dividend was issued on the 9th of December 2015. The firm had 3:2 split on the 28th of December 2000. Based on the measurements of operating efficiency obtained from CryoLife's historical financial statements, CryoLife is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.CryoLife Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CryoLife has an asset utilization ratio of 41.14 percent. This implies that the Company is making €0.41 for each dollar of assets. An increasing asset utilization means that CryoLife is more efficient with each dollar of assets it utilizes for everyday operations.CryoLife Ownership Allocation
CryoLife holds a total of 40.56 Million outstanding shares. The majority of CryoLife outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CryoLife to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in CryoLife. Please pay attention to any change in the institutional holdings of CryoLife as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CryoLife Profitability Analysis
The company reported the revenue of 313.79 M. Net Loss for the year was (19.19 M) with profit before overhead, payroll, taxes, and interest of 202.52 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CryoLife's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CryoLife and how it compares across the competition.
About CryoLife Valuation
The stock valuation mechanism determines CryoLife's current worth on a weekly basis. Our valuation model uses a comparative analysis of CryoLife. We calculate exposure to CryoLife's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CryoLife's related companies.CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.
8 Steps to conduct CryoLife's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CryoLife's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CryoLife's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CryoLife's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CryoLife's revenue streams: Identify CryoLife's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CryoLife's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CryoLife's growth potential: Evaluate CryoLife's management, business model, and growth potential.
- Determine CryoLife's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CryoLife's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CryoLife Stock analysis
When running CryoLife's price analysis, check to measure CryoLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoLife is operating at the current time. Most of CryoLife's value examination focuses on studying past and present price action to predict the probability of CryoLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoLife's price. Additionally, you may evaluate how the addition of CryoLife to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |